Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia.

Authors :: Todisco E
Gigli F
Sammassimo S
Camisaschi C
Mancuso P
Ronchini C
Ramadan S
Bertolini F
Pastano R
Tarella C
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2020 Sep; Vol. 61 (9), pp. 2277-2279. Date of Electronic Publication: 2020 May 02.
Publication Year :: 2020

Subjects :: Humans
Neoplasm, Residual
Sulfonamides therapeutic use
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Leukemia, Myeloid, Acute drug therapy

Full Text Access

Tools